stage III – Page 3 – Communicable Diseases Research

Acute kidney injury in hospitalized patients with COVID-19 (retrospective study)

Research

Published on 2021-01-122022-10-31
Journal: The Egyptian Journal of Bronchology [Category] COVID-19,

[키워드] 2019 novel coronavirus Acute kidney injury admitted to ICU age AKI analyzed Blood city CKD coded collected conducted COVID-19 COVID-19 patient Critical detect discharge Epidemic evaluate evaluated Follow-up Gender higher risk hospital Hospitalized hospitalized COVID-19 patients hospitalized patient incidence increase in kidney Kidney injury male medical records Mortality mortality rate nervous system Occurrence organ injury pandemic Patient patients with COVID-19 public health emergency researcher Result Retrospective study SARS-COV-2 infection serum creatinine severity spread to stage III the patient virus WHO with COVID-19 World Health Organization Wuhan, China
[DOI] 10.1186/s43168-021-00056-z PMC 바로가기 [Article Type] Research

Videoconferenced Yoga Interventions for Cancer Patients and their Caregivers during the COVID-19 Pandemic: A Report from a Clinician’s Perspective

Randomized Controlled Trial

Published on 2021-01-012022-10-05
Journal: Integrative cancer therapies [Category] 임상,

[키워드] acceptability age All participant approach benefit Cancer cancer patient Caregiver connection COVID-19 declined described enrolled female Intervention male modifications Older pandemic participant patient-caregiver dyads patients Radiotherapy report stage III study participant Trial videoconference delivery white yoga
[DOI] 10.1177/15347354211019111 PMC 바로가기 [Article Type] Randomized Controlled Trial

Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?—Lessons Learned From Cancer

Immunology

Published on 2020-09-302022-11-01
Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS,

[키워드] ACE Activation airway angiotensin-converting enzyme 2 Anxiety ARDS ARs Beta adrenergic receptors beta-blockers blocking Can clinical settings combat contagious COVID-19 Cytokine storm dendritic cells disease droplets early phase expressed global public health globe human cell hyperinflammation Hyperinflammatory syndrome IFN IL-6 Immune cell immune response Immunity Inflammation Inflammatory cytokine macrophages modulate New Prevent progression receptor reduce respiratory Saliva SARS-CoV-2 SARS-COV-2 infection SARS-CoV2 severe pneumonia Spread stage III Structural analysis T lymphocytes target the disease the patient the spike protein therapy treat Ventilation virus
[DOI] 10.3389/fimmu.2020.588724 PMC 바로가기 [Article Type] Immunology

Aspirin with or without statin in the treatment of endotheliitis, thrombosis, and ischemia in coronavirus disease

Major Article

Published on 2020-09-212022-10-28
Journal: Revista da Sociedade Brasileira de Medicina Tropic [Category] COVID-19, MERS, SARS,

[키워드] age Aspirin benefit Case series changes clinical evolution clinical trial Comorbidity complementary contributed coronavirus disease COVID-19 diagnosis of COVID-19 discharged Endothelial dysfunction Endotheliitis Endothelium evaluate Evolution Hospitalization Hydroxymethylglutaryl-CoA Reductase Inhibitors hypothese Ischemia laboratory-confirmed medication Patient poor prognosis Prevent Prophylaxis reported resolved risk factor secondary bacterial stage III statin Support survival Symptom Symptoms the disease Therapeutic approach therapy thrombosis thrombotic Treatment vascular disease vessels
[DOI] 10.1590/0037-8682-0472-2020 PMC 바로가기 [Article Type] Major Article

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study

Original Article

Published on 2020-09-062022-10-28
Journal: Annals of Hematology [Category] COVID-19,

Public perspectives on protective measures during the COVID-19 pandemic in the Netherlands, Germany and Italy: A survey study

Research Article

Published on 2020-08-052022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,